splenic infarction: Insufficiency of arterial or venous blood supply to the spleen due to emboli, thrombi, vascular torsion, or pressure that produces a macroscopic area of necrosis. (From Stedman, 25th ed)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
191 |
4. Check minimum number of eventsNone |
191 |
5. Include endpointsNone |
191 |
6. Filter based on genotype QC (FinnGen only) |
191 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D73
- Name in latin
- Infarctus lienis
Similar endpoints
↥List of similar endpoints to
Infarction of spleen
based on the number of shared cases.
Similar with more cases:
- Diseases of spleen
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1148 | 520 | 622 |
| Only index persons | 1015 | 470 | 545 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 67.93 | 70.81 | 65.47 |
| Only index persons | 67.43 | 70.42 | 64.85 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 191 | 90 | 101 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | 68.97 | 68.81 | 69.10 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 173
- Matched controls
- 1730
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D73.5
ICD-10 Finland
Infarction of spleen
+∞
247.0
172
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
8.1
24.4
61
109
N28.0
ICD-10 Finland
Ischaemia and infarction of kidney
250.3
22.1
22
*
L01XX05
ATC
hydroxycarbamide; oral
125.2
21.1
22
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.5
18.2
33
32
JN3AD
NOMESCO Finland
Abdominal CT examination
8.2
17.2
40
61
R10.1
ICD-10 Finland
Pain localized to upper abdomen
5.2
16.3
58
154
D45
ICD-10 Finland
Polycythaemia vera
93.8
15.9
17
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.4
14.8
48
114
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
14.5
50
127
B01AB05
ATC
enoxaparin; parenteral
3.6
14.2
91
405
C03CA01
ATC
furosemide; systemic
3.4
13.0
88
401
B01AA03
ATC
warfarin; systemic
3.7
12.8
69
262
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.3
12.0
86
403
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
11.9
53
170
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
11.6
11
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
11.5
108
604
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.5
11.1
62
238
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.7
10.9
54
189
M04AA01
ATC
allopurinol; systemic
4.2
10.6
44
131
XW000
NOMESCO Finland
Bone marrow biopsy
7.2
10.0
24
38
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
9.8
59
237
D75.2
ICD-10 Finland
Essential thrombocytosis
+∞
9.5
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.6
9.3
33
84
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
9.2
73
350
TPH07
NOMESCO Finland
Cathetrisation of artery
4.0
9.1
38
113
WW500
NOMESCO Finland
Blood transfusion
7.9
9.0
20
28
WX892
NOMESCO Finland
Monitored bed care
4.8
9.0
30
72
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
5.1
8.9
28
63
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
52.7
8.8
10
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.7
8.8
25
50
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
15.5
8.3
13
9
N02AA05
ATC
oxycodone; systemic
3.2
8.2
46
174
B01AB10
ATC
tinzaparin; parenteral
4.4
8.1
29
75
C07AB07
ATC
bisoprolol; oral
2.5
7.9
105
660
I50.9
ICD-10 Finland
Heart failure, unspecified
3.2
7.9
46
177
A02BC05
ATC
esomeprazole; systemic
2.5
7.4
84
479
AA1AD
NOMESCO Finland
CT of head and brain
2.6
7.2
63
310
R11
ICD-10 Finland
Nausea and vomiting
4.3
7.2
26
68
JAH00
NOMESCO Finland
Laparotomy
8.9
7.0
14
17
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.8
6.9
48
207
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.6
6.8
57
273
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
17.6
6.8
10
6
A02BC02
ATC
pantoprazole; systemic
2.4
6.6
125
897
N02AX02
ATC
tramadol; systemic, rectal
2.3
6.6
89
543
ECB00
NOMESCO Finland
Suture of gingiva
7.9
6.6
14
19
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
7.9
6.6
14
19
R10.0
ICD-10 Finland
Acute abdomen
7.9
6.6
14
19
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.0
6.5
17
31
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.9
6.5
26
75
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
15.1
6.5
10
7
D70.89
ICD-10 Finland
Neutropenic splenomegaly
72.4
6.5
7
*
K86.3
ICD-10 Finland
Pseudocyst of pancreas
72.4
6.5
7
*
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
72.4
6.5
7
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.9
6.3
40
163
JN4BD
NOMESCO Finland
Extensive body CT
3.2
6.3
34
122
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
6.3
6
*
SPAT1074
SPAT
Venesection
+∞
6.3
6
*
I50.0
ICD-10 Finland
Congestive heart failure
4.0
6.2
24
67
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.8
6.2
25
73
H02AB06
ATC
prednisolone; systemic
2.2
6.1
95
612
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
54
48
15.29
54.25
4.1
1.7
u/ml
0.3
0.3
0.18
46
20
(3023368) Bacteria identified in Blood by Culture
132
452
7.22
39.53
10.0
4.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
27
17
18.33
32.06
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
23
15
17.30
26.68
1.7
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
27
24
12.94
26.37
1.4
1.2
u/ml
3.9
6.3
—
15
9
(3032080) INR in Blood by Coagulation assay
146
694
5.68
26.04
20.8
9.5
inr
1.4
1.3
0.78
40
211
(3003458) Phosphate [Moles/volume] in Serum or Plasma
74
218
4.91
24.16
6.2
5.2
mmol/l
1.1
1.0
0.66
67
201
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
26
25
11.88
24.10
1.3
1.0
u/l
73.0
13.1
1.28
19
20
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
120
517
4.55
23.56
6.5
2.4
u/l
57.2
57.0
0.01
115
480
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
102
400
4.33
22.56
3.3
2.0
mg/l
4.4
3.3
1.87
95
342
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
74
230
4.62
22.35
3.5
2.5
%
22.2
22.5
0.05
63
198
(42870588) Differential panel, method unspecified - Blood
115
495
4.33
22.26
14.1
5.2
—
—
—
0
0
(4306422)
22
19
12.96
21.74
1.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
26
30
9.87
21.16
2.0
2.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
146
770
4.80
20.77
11.1
5.5
e9/l
2.0
1.8
1.07
136
682
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
104
5.51
20.23
2.2
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
147
790
4.74
20.10
12.7
6.6
mmol/l
1.2
1.2
0.16
132
663
(3013650) Neutrophils [#/volume] in Blood by Automated count
156
882
5.19
19.77
19.1
8.8
e9/l
5.5
4.2
2.35
146
770
(3001604) Monocytes [#/volume] in Blood
142
755
4.43
19.44
10.9
5.3
e9/l
0.7
0.6
1.99
132
652
(3006315) Basophils [#/volume] in Blood
142
758
4.40
19.26
11.0
5.4
e9/l
0.1
0.0
1.35
132
656
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
22
24
10.23
18.57
1.2
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
143
780
4.32
18.48
13.2
5.4
e9/l
0.2
0.2
0.02
133
690
(21494434) Karyotype in Bone marrow
19
17
12.30
18.27
1.6
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
109
500
3.75
18.21
6.3
2.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
47
118
4.96
18.20
7.8
4.6
%
0.5
0.3
0.51
22
32
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
77
5.72
17.69
2.0
1.8
g/l
1.3
1.6
0.79
32
65
(3017181) Myelocytes/100 leukocytes in Blood
50
135
4.66
17.68
8.2
4.4
%
1.0
1.0
0.03
28
50
(3023520) Reticulocytes [#/volume] in Blood
54
157
4.40
17.34
4.3
2.7
e9/l
84.6
65.9
2.59
44
126
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
31
56
6.41
17.12
1.2
4.4
mg/l
41.5
30.3
0.56
25
45
(3034860) Kappa light chains.free [Mass/volume] in Serum
31
56
6.41
17.12
1.2
4.4
mg/l
50.8
180.2
0.59
25
45
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
134
723
3.86
17.04
10.7
4.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
37
7.62
16.57
1.2
5.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
68
243
3.79
16.29
3.3
2.0
—
—
—
0
0
(4268621)
17
16
11.57
15.76
2.1
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
48
137
4.34
15.68
8.3
8.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
82
342
3.45
15.34
2.7
1.8
mg/l
2.0
1.5
0.62
69
277
(3026493) Urate [Moles/volume] in Serum or Plasma
93
421
3.36
15.19
5.2
3.0
umol/l
371.6
7461.9
1.96
84
355
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
17
10.88
15.13
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
42
113
4.48
14.75
1.3
2.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
44
125
4.27
14.38
8.7
4.5
%
0.2
0.2
0.01
25
43
(3014576) Chloride [Moles/volume] in Serum or Plasma
62
225
3.60
14.29
9.2
6.6
mmol/l
103.7
103.7
0.03
62
219
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
27
8.16
14.26
1.4
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
79
335
3.32
14.20
3.7
3.0
mosm/kgh2o
517.9
554.6
0.94
73
285
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
67
257
3.48
14.15
3.2
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
103
512
3.20
14.11
4.8
3.3
e6/l
21.2
181.4
0.68
89
392
(3016502) Oxygen saturation in Arterial blood
53
175
3.81
14.04
13.0
7.5
%
95.0
95.6
0.18
53
170
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
108
553
3.19
14.03
4.4
3.0
ng/l
1511.2
1342.0
0.29
100
458
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
45
6.24
13.76
1.5
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
12
12.51
13.68
1.1
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
47
146
3.94
13.55
2.6
2.6
ug/l
7.5
8.0
0.08
38
132
(3012544) pH of Venous blood
51
168
3.78
13.52
5.3
3.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
41
117
4.19
13.27
8.6
4.7
%
0.2
0.2
0.02
22
37
(3000850) Epithelial cells [#/volume] in Urine
79
347
3.18
13.22
3.4
2.6
e6/l
7.8
4.3
0.78
73
307
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
39
108
4.28
13.12
1.6
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
16
18
9.61
13.07
1.2
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
110
586
3.07
13.04
5.7
3.8
e6/l
153.8
68.1
0.32
92
423
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
53
184
3.60
12.95
2.9
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
97
484
3.04
12.90
6.7
3.2
u/l
41.3
30.9
0.85
97
461
(36304419) Bacteria [Presence] in Urine
92
447
3.04
12.82
4.4
3.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
99
501
3.03
12.82
5.5
3.9
ph
7.4
7.4
0.19
18
110
(3030467) Casts [#/volume] in Urine by Automated count
95
473
3.01
12.62
4.6
3.1
e6/l
0.4
0.5
0.26
82
350
(3015377) Calcium [Moles/volume] in Serum or Plasma
99
505
2.99
12.57
4.0
3.3
mmol/l
2.3
2.3
0.22
88
440
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
19
9.10
12.55
1.2
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
110
601
2.96
12.21
5.2
3.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
52
185
3.49
12.17
1.4
1.3
titre
512.0
330.3
—
10
39
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
43
5.94
12.15
1.9
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
186
3.47
12.06
3.1
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
47
158
3.62
11.99
5.3
3.7
mmol/l
2.5
2.0
0.46
36
126
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
53
193
3.42
11.95
13.0
6.9
kpa
5.0
5.1
0.29
53
185
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
49
170
3.53
11.91
1.5
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
53
194
3.40
11.84
13.1
6.9
mmol/l
1.9
1.0
0.88
43
157
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
70
306
3.03
11.57
6.3
3.6
ng/l
476.8
162.1
1.12
63
254
(3004119) Hemoglobin [Mass/volume] in Venous blood
37
109
3.97
11.38
4.9
3.5
g/l
119.8
126.0
0.75
37
109
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
79
372
2.92
11.38
6.2
2.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
42
5.79
11.36
2.3
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
73
333
2.93
11.10
2.2
1.8
nmol/l
1206.2
1324.7
0.53
61
245
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
150
3.51
10.92
1.4
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
52
198
3.23
10.81
1.6
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
54
211
3.17
10.75
44.0
22.8
inr
1.8
1.3
—
5
30
(3019060) Gas panel - Arterial blood
36
111
3.76
10.34
12.1
4.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
78
388
2.71
9.86
17.0
6.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
19
37
5.59
9.58
1.6
1.3
g/l
0.2
0.2
0.34
19
37
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
37
5.59
9.58
1.6
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
31
91
3.87
9.52
19.3
8.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
34
108
3.61
9.32
14.6
6.2
mmol/l
23.8
24.4
0.22
34
100
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
29
84
3.89
9.06
2.7
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
47
186
3.03
9.03
2.1
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
41
150
3.21
8.99
6.5
2.6
u/l
36.0
34.1
0.08
35
121
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
100
3.64
8.97
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
36
5.42
8.81
1.4
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
151
1077
2.92
8.66
7.4
4.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
45
4.85
8.59
2.1
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
18
37
5.27
8.55
1.1
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
13
8.92
8.55
1.3
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
110
678
2.47
8.53
6.8
3.9
ng/l
116.2
41.2
0.54
93
513
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
7
18.16
8.18
1.4
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
158
1169
3.03
8.18
6.8
4.1
mm/h
17.8
13.0
2.93
151
1063
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
39
4.99
8.06
1.7
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
101
610
2.39
8.05
2.6
2.3
nmol/l
81.1
77.8
0.47
90
528
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
28
87
3.60
7.89
4.5
2.8
%
1.4
1.2
0.45
28
87
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
22
6.27
7.48
8.9
3.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
46
4.48
7.47
2.2
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
55
262
2.54
7.29
4.2
3.1
e6/l
5.7
2.3
0.84
33
144
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
105
665
2.29
7.26
2.7
1.9
pmol/l
85.9
93.9
1.18
73
324
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
66
3.83
7.25
1.4
2.3
g/l
7.0
7.7
0.70
18
52
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
66
3.83
7.25
1.4
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
66
3.83
7.25
1.4
2.3
g/l
3.4
3.7
0.80
18
49
(4035726)
38
152
2.87
7.06
1.8
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
74
410
2.31
6.98
2.2
1.5
nmol/l
18.7
20.9
0.63
66
343
(3027273) Bicarbonate [Moles/volume] in Venous blood
26
85
3.38
6.76
6.1
3.8
mmol/l
24.2
24.7
0.21
26
85
(3021589) Normoblasts [#/volume] in Blood
107
700
2.20
6.63
23.6
10.0
e9/l
0.1
0.0
0.65
96
575
(40760892) CBC W Ordered Manual Differential panel - Blood
64
341
2.32
6.55
9.1
5.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
82
486
2.20
6.48
4.2
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
56
283
2.38
6.45
3.9
2.8
e6/l
1.3
1.0
0.51
34
162
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
34
4.70
6.36
1.4
1.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
16
39
4.39
6.22
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
68
388
2.17
5.79
1.4
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
89
3.08
5.66
1.3
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
29
4.74
5.60
1.8
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
115
806
2.07
5.60
8.4
5.2
estimate
0.0
0.0
0.00
30
166
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
38
4.20
5.55
1.5
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
116
820
2.06
5.46
6.2
3.9
estimate
0.0
0.0
0.00
31
158
(40765096) Chromosome analysis panel by Banding
8
5
16.60
5.46
1.0
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
114
804
2.04
5.37
6.2
3.8
estimate
0.0
0.0
0.00
29
168
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
12
26
4.86
5.34
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
35
4.24
5.27
1.9
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
35
4.24
5.27
2.2
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
116
829
2.02
5.20
3.4
2.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
6
13.83
5.12
1.8
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
27
4.68
5.11
1.1
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
179
1538
3.61
4.97
50.1
15.0
mg/l
33.4
23.9
4.43
174
1227
(3024928) Oxygen saturation in Venous blood
14
37
4.00
4.91
3.4
2.9
—
—
—
0
0
(44790049)
11
24
4.80
4.84
2.8
1.6
—
—
—
0
0
(44806118)
11
24
4.80
4.84
2.8
1.6
—
—
—
0
0
(44790047)
11
24
4.80
4.84
2.8
1.6
—
—
—
0
0
(44790048)
11
24
4.80
4.84
2.8
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
20
5.22
4.83
2.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
16
48
3.55
4.72
6.6
3.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
29
4.35
4.70
1.8
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
54
303
2.09
4.68
3.8
3.2
mmol/l
2.5
2.4
0.63
45
268
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
34
4.03
4.62
1.1
1.2
—
—
—
0
0
(3020891) Body temperature
19
65
3.14
4.59
7.0
4.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
8
10.37
4.56
2.3
2.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
8
10.37
4.56
1.1
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
41
211
2.20
4.40
1.5
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
56
3.23
4.36
2.2
2.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
9
9.21
4.32
1.8
2.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
9
9.21
4.32
1.8
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
91
627
1.86
4.27
2.5
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
52
3.27
4.19
2.5
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
51
291
2.03
4.18
1.6
1.4
g/l
2.8
2.6
0.19
37
175
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
23
4.53
4.14
2.0
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
14
42
3.52
4.13
1.1
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
162
1362
2.25
4.02
51.2
15.6
%
37.3
39.9
2.39
93
925
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
29
3.96
3.86
1.4
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
38
201
2.11
3.79
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
25
4.17
3.75
1.4
1.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
8
12
6.90
3.71
2.3
1.2
e6/l
594.6
705.1
—
8
7
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
51
3.11
3.66
2.4
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
126
989
1.81
3.62
7.4
3.2
u/l
76.6
53.2
2.06
120
920
(3051593) INR in Capillary blood by Coagulation assay
7
9
8.02
3.59
12.4
8.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
13
6.37
3.54
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
42
3.25
3.44
1.2
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
42
3.25
3.44
1.2
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
42
3.25
3.44
1.2
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
40
224
1.99
3.41
1.3
1.3
u/ml
31.5
12.2
0.55
15
93
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
10
7.22
3.39
1.3
2.2
umol/l
12.3
13.0
—
7
10
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
43
248
1.95
3.37
1.3
1.3
iu/ml
37.2
42.3
0.13
13
77
(3000494) Fungus identified in Specimen by Culture
36
195
2.04
3.36
2.5
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
19
78
2.59
3.33
1.9
1.9
u/l
41.6
39.2
0.15
14
70
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
31
160
2.12
3.28
1.6
1.5
%
1.6
1.6
0.01
25
131
(3044941) Cell count panel - Synovial fluid
9
19
4.91
3.28
1.6
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
20
4.67
3.15
1.1
1.1
—
—
—
0
0
(4062490)
8
16
5.17
3.08
2.6
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
16
5.17
3.08
1.9
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
16
5.17
3.08
7.1
3.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
16
5.17
3.08
1.1
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
56
362
1.77
3.06
6.0
3.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
12
6.01
3.05
7.9
3.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
12
6.01
3.05
1.4
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
137
1132
1.74
2.98
6.7
4.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
67
459
1.71
2.97
6.8
4.2
estimate
0.0
0.0
0.00
26
162
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
30
3.46
2.95
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
30
3.46
2.95
1.2
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
22
4.24
2.92
4.4
2.0
pg
32.7
33.7
—
9
22
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
86
633
1.65
2.89
7.0
4.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
47
2.89
2.88
2.3
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
18
4.59
2.82
1.1
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
48
2.83
2.78
2.8
4.2
g/l
0.3
0.1
—
6
19
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
138
1153
1.71
2.77
4.9
3.7
pmol/l
15.2
15.0
0.47
131
1020
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
6
8.51
2.76
1.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
37
3.09
2.74
1.1
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
10
6.15
2.72
1.7
2.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
32
180
1.93
2.69
1.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
74
534
1.63
2.64
3.5
3.9
mg/mmol
21.7
7.6
0.64
57
337
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
15
4.80
2.62
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
20
4.13
2.60
2.1
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
20
4.13
2.60
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
55
370
1.68
2.56
1.8
1.8
pmol/l
475.0
448.6
0.27
49
294
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
7
7.29
2.56
1.8
2.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
65
0.00
2.47
0.0
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
12
5.12
2.42
2.5
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
28
156
1.93
2.42
1.7
2.2
ug/g
473.2
109.1
0.76
22
123
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
35
2.96
2.34
9.2
3.8
%
59.3
61.3
—
10
35
(3019230) Fractional oxyhemoglobin in Venous blood
9
28
3.32
2.34
1.6
1.7
%
45.0
62.1
—
9
28
(3035880) pH of Pleural fluid
6
13
4.73
2.29
1.5
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
18
3.99
2.27
1.6
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
12
48
2.60
2.23
3.8
2.6
mmol/l
24.5
24.6
—
7
41
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
20
102
2.07
2.20
3.9
4.3
mmol/l
2.1
1.8
0.17
14
79
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
19
3.78
2.17
2.3
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
13
56
2.42
2.10
4.1
3.3
mmol/l
4.0
3.9
0.48
13
49
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
10
5.10
2.08
1.0
1.4
g/l
1.5
1.5
—
5
10
(3023511) Choriogonadotropin [Units/volume] in Urine
5
10
5.10
2.08
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
50
346
1.60
2.06
7.4
4.2
kg/l
1.0
1.0
—
9
37
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
15
4.09
2.05
1.3
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
15
4.09
2.05
7.7
3.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
26
3.17
2.04
1.5
1.5
ug/l
36.1
16.5
—
8
26
(36660697) Celiac disease serology panel - Serum
19
98
2.04
2.03
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
177
1637
2.11
1.98
45.8
13.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
62
455
1.54
1.97
5.9
3.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
11
4.63
1.95
1.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
16
3.83
1.95
2.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
16
3.83
1.95
2.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
16
3.83
1.95
2.0
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
16
3.83
1.95
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
65
2.25
1.93
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
22
3.26
1.90
1.9
1.7
—
—
—
0
0
(3013512) EKG study
67
505
1.50
1.87
6.1
4.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
17
3.61
1.85
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
17
3.61
1.85
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
17
3.61
1.85
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
17
3.61
1.85
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
12
4.25
1.83
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
23
3.12
1.81
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
68
517
1.49
1.81
3.0
3.0
mmol/l
6.9
7.4
0.47
58
417
(3012516) Albumin [Mass/volume] in Urine
66
499
1.49
1.81
3.1
3.1
mg/l
935.5
51.8
0.51
51
324
(40761535) Cells panel - Urine sediment
24
141
1.80
1.78
6.2
3.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
189
1.70
1.76
7.3
3.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
18
3.41
1.76
1.2
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
5
13
3.92
1.72
1.0
1.2
nmol/l
224.6
362.3
—
5
8
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
13
3.92
1.72
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
13
3.92
1.72
1.0
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
62
2.18
1.70
3.0
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
31
2.65
1.68
2.8
2.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
19
3.23
1.67
2.2
1.5
—
—
—
0
0
(3019225) pH of Specimen
23
137
1.77
1.64
5.7
4.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
178
1667
2.00
1.63
54.1
17.9
umol/l
87.3
80.6
1.60
178
1667
(3045788) Cell count panel - Pleural fluid
5
14
3.64
1.62
2.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
14
3.64
1.62
1.2
1.6
%
6.1
12.1
—
5
14
(3045424) Erythrocytes [Presence] in Urine
6
20
3.06
1.59
1.0
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
168
1552
1.68
1.55
5.5
4.8
mmol/l
6.4
6.1
1.76
151
1398
(3017732) Neutrophils [#/volume] in Blood
19
109
1.83
1.53
2.3
2.5
e9/l
5.1
3.9
0.42
13
84
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
37
2.50
1.50
1.1
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
28
2.56
1.46
1.4
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
39
531
0.67
1.45
2.7
3.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
29
2.47
1.40
5.0
3.8
mmol/l
103.7
105.7
—
7
29
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
29
2.47
1.40
5.0
3.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
29
2.47
1.40
5.0
3.8
mmol/l
4.1
4.0
—
7
29
(3023419) Bacteria identified in Sputum by Culture
6
23
2.66
1.38
1.2
2.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
17
2.99
1.36
1.2
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
43
2.15
1.32
1.9
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
24
155
1.63
1.31
4.1
3.7
mmol/l
1.2
1.2
0.16
24
137
(3008037) Lactate [Moles/volume] in Venous blood
10
48
2.14
1.30
5.5
4.2
mmol/l
1.7
1.4
—
10
48
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
18
2.82
1.29
1.8
1.2
nmol/l
—
—
—
0
0
(3022313) Gas panel - Capillary blood
14
77
1.88
1.29
3.4
4.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
44
2.10
1.28
2.8
2.4
mg/l
1.5
1.8
—
9
38
(3038515) Glucose [Moles/volume] in Venous blood
9
45
2.05
1.25
6.0
4.3
mmol/l
7.2
7.6
—
9
45
(3019832) Treponema pallidum Ab [Presence] in Serum
14
78
1.86
1.25
1.1
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
162
1504
1.51
1.22
39.0
14.2
ml/min/173m2
73.9
77.3
1.04
150
1229
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
161
1495
1.49
1.19
8.1
6.2
mmol/mol
42.2
40.5
0.92
150
1381
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
29
201
1.52
1.19
18.7
8.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
41
1.99
1.10
1.6
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
21
2.42
1.09
2.2
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
32
2.23
1.09
3.7
2.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
34
2.10
1.04
1.0
1.3
—
—
—
0
0
(4010399)
19
125
1.58
0.98
1.5
1.4
—
—
—
0
0
(3000492) Spirometry study
20
134
1.55
0.96
1.5
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
27
2.26
0.94
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
40
311
1.36
0.91
1.4
1.2
u/ml
1.2
0.8
—
8
93
(40761536) Microorganisms panel - Urine sediment
22
153
1.49
0.90
6.9
3.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
179
1724
1.61
0.81
70.6
21.9
g/l
124.7
135.4
10.94
179
1696
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
47
1.73
0.81
1.0
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
33
1.84
0.79
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
75
1.64
0.77
1.8
2.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
54
1.70
0.76
1.1
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
178
0.65
0.68
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
28
1.81
0.66
2.2
3.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
156
1488
1.26
0.57
5.3
4.2
mmol/l
1.5
1.3
3.69
141
1349
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
36
1.69
0.57
1.8
1.5
mg/l
3.0
2.3
—
6
26
(1616796) Gas panel - Central venous blood
6
38
1.60
0.55
5.2
3.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
67
1.52
0.50
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
219
1.27
0.48
1.5
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
56
1.45
0.43
5.9
5.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
70
1.45
0.42
1.4
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
10
70
1.45
0.42
1.2
1.2
u/ml
82.3
230.0
—
10
65
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
32
1.58
0.42
1.0
1.2
u/l
13.4
6.7
—
5
26
(3004775) Volume in Urine collected for unspecified duration
0
15
0.00
0.41
0.0
2.5
—
627.4
—
0
8
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
7.9
—
0
7
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
35.4
—
0
7
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
507.1
—
0
9
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
252.7
—
0
9
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
34
1.48
0.40
1.0
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
34
1.48
0.40
1.4
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
114
0.69
0.38
1.3
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
90
1.36
0.36
6.8
4.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
83
1.35
0.33
2.9
2.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
163
1590
1.17
0.28
6.2
5.3
mmol/l
2.3
2.7
7.45
150
1443
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
159
1549
1.16
0.28
5.7
4.7
mmol/l
4.0
4.5
9.31
147
1413
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
61.7
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
35
376
0.92
0.14
2.4
3.2
ug/l
0.6
0.8
1.10
21
262
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
95
0.84
0.14
1.4
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
18
198
0.90
0.11
6.0
4.7
%
30.7
31.9
0.13
12
130
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
49
513
0.94
0.11
3.4
4.6
%
22.2
21.1
0.15
19
270
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
156
1540
1.07
0.10
5.7
4.7
mmol/l
1.2
1.4
11.84
140
1400
(3008898) HLA-B27 [Presence]
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
64
660
0.95
0.08
5.0
5.1
ug/l
4.2
2.9
0.30
54
584
(3017446) Testosterone [Moles/volume] in Serum or Plasma
14
127
1.11
0.08
2.4
2.0
nmol/l
9.8
13.9
0.78
14
115
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
87
1.04
0.07
1.4
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
112
1.08
0.03
4.3
3.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
152
1.06
0.02
1.7
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
94
1.07
0.01
1.7
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
112.1
—
0
9
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
91
0.99
0.00
1.1
1.3
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.2
—
4.3
—
0
6
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_INFARCTSPLEEN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_INFARCTSPLEEN | 4.274 [2.49, 7.33] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.268 |
During the follow-up period (1.1.1998 — 31.12.2019), 141 out of 337 females with D3_INFARCTSPLEEN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_INFARCTSPLEEN | 3.945 [2.59, 6.01] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 157 out of 407 males with D3_INFARCTSPLEEN died.
Mortality risk
Mortality risk for people of age
years, who have D3_INFARCTSPLEEN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.375% | 0.58% |
| 5 | 2.654% | 3.864% |
| 10 | 6.187% | 9.639% |
| 15 | 12.077% | 17.816% |
| 20 | 20.399% | 28.01% |
Relationships between endpoints
↥Index endpoint: D3_INFARCTSPLEEN – Infarction of spleen
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data